These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cancer cachexia decreases specific force and accelerates fatigue in limb muscle. Roberts BM; Frye GS; Ahn B; Ferreira LF; Judge AR Biochem Biophys Res Commun; 2013 Jun; 435(3):488-92. PubMed ID: 23673294 [TBL] [Abstract][Full Text] [Related]
3. Diaphragm and ventilatory dysfunction during cancer cachexia. Roberts BM; Ahn B; Smuder AJ; Al-Rajhi M; Gill LC; Beharry AW; Powers SK; Fuller DD; Ferreira LF; Judge AR FASEB J; 2013 Jul; 27(7):2600-10. PubMed ID: 23515443 [TBL] [Abstract][Full Text] [Related]
4. Voluntary exercise does not improve muscular properties or functional capacity during C26-induced cancer cachexia in mice. Hiroux C; Dalle S; Koppo K; Hespel P J Muscle Res Cell Motil; 2021 Jun; 42(2):169-181. PubMed ID: 33606189 [TBL] [Abstract][Full Text] [Related]
5. Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice. Murphy KT; Chee A; Gleeson BG; Naim T; Swiderski K; Koopman R; Lynch GS Am J Physiol Regul Integr Comp Physiol; 2011 Sep; 301(3):R716-26. PubMed ID: 21677277 [TBL] [Abstract][Full Text] [Related]
6. Muscle oxidative capacity during IL-6-dependent cancer cachexia. White JP; Baltgalvis KA; Puppa MJ; Sato S; Baynes JW; Carson JA Am J Physiol Regul Integr Comp Physiol; 2011 Feb; 300(2):R201-11. PubMed ID: 21148472 [TBL] [Abstract][Full Text] [Related]
7. Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia. Murphy KT; Chee A; Trieu J; Naim T; Lynch GS Dis Model Mech; 2012 Jul; 5(4):533-45. PubMed ID: 22563056 [TBL] [Abstract][Full Text] [Related]
8. Cachectic skeletal muscle response to a novel bout of low-frequency stimulation. Puppa MJ; Murphy EA; Fayad R; Hand GA; Carson JA J Appl Physiol (1985); 2014 Apr; 116(8):1078-87. PubMed ID: 24610533 [TBL] [Abstract][Full Text] [Related]
9. The mechanisms of cachexia underlying muscle dysfunction in COPD. Remels AH; Gosker HR; Langen RC; Schols AM J Appl Physiol (1985); 2013 May; 114(9):1253-62. PubMed ID: 23019314 [TBL] [Abstract][Full Text] [Related]
11. Skeletal muscle function during the progression of cancer cachexia in the male Apc VanderVeen BN; Hardee JP; Fix DK; Carson JA J Appl Physiol (1985); 2018 Mar; 124(3):684-695. PubMed ID: 29122966 [TBL] [Abstract][Full Text] [Related]
12. Physiological characterization of a mouse model of cachexia in colorectal liver metastases. Murphy KT; Struk A; Malcontenti-Wilson C; Christophi C; Lynch GS Am J Physiol Regul Integr Comp Physiol; 2013 May; 304(10):R854-64. PubMed ID: 23485871 [TBL] [Abstract][Full Text] [Related]
13. PGC1α overexpression preserves muscle mass and function in cisplatin-induced cachexia. Huot JR; Pin F; Chatterjee R; Bonetto A J Cachexia Sarcopenia Muscle; 2022 Oct; 13(5):2480-2491. PubMed ID: 35903870 [TBL] [Abstract][Full Text] [Related]
14. Role of PARP activity in lung cancer-induced cachexia: Effects on muscle oxidative stress, proteolysis, anabolic markers, and phenotype. Chacon-Cabrera A; Mateu-Jimenez M; Langohr K; Fermoselle C; García-Arumí E; Andreu AL; Yelamos J; Barreiro E J Cell Physiol; 2017 Dec; 232(12):3744-3761. PubMed ID: 28177129 [TBL] [Abstract][Full Text] [Related]